Stoke Therapeutics Stock Price Prediction
| STOK Stock | USD 11.94 0.07 0.59% |
Oversold Vs Overbought
52
Oversold | Overbought |
Stoke Therapeutics stock price prediction is an act of determining the future value of Stoke Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Stoke Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Stoke Therapeutics and does not consider all of the tangible or intangible factors available from Stoke Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Stoke Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Stoke Therapeutics based on different types of headlines from major news networks to social media. The Stoke stock price prediction module provides an analysis of price elasticity to changes in media outlook on Stoke Therapeutics over a specific investment horizon. Using Stoke Therapeutics hype-based prediction, you can estimate the value of Stoke Therapeutics from the perspective of Stoke Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Stoke Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Stoke Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Stoke because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Stoke Therapeutics after-hype prediction price | USD 11.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Stoke |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stoke Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Stoke Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Stoke Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Stoke Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Stoke Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Stoke Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Stoke Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Stoke Therapeutics' historical news coverage. Stoke Therapeutics' after-hype downside and upside margins for the prediction period are 1.07 and 22.81, respectively. We have considered Stoke Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Stoke Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Stoke Therapeutics is based on 3 months time horizon.
Stoke Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Stoke Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stoke Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Stoke Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.10 | 10.87 | 0.00 | 0.06 | 0 Events / Month | 3 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.94 | 11.94 | 0.00 |
|
Stoke Therapeutics Hype Timeline
Stoke Therapeutics is at this time traded for 11.94. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.06. Stoke is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 2.1%. %. The volatility of related hype on Stoke Therapeutics is about 36233.33%, with the expected price after the next announcement by competition of 11.88. About 81.0% of the company shares are owned by institutional investors. The book value of Stoke Therapeutics was at this time reported as 3.48. The company has Price/Earnings To Growth (PEG) ratio of 0.27. Stoke Therapeutics recorded a loss per share of 2.38. The entity had not issued any dividends in recent years. The firm had 1:9 split on the 6th of June 2019. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections.Stoke Therapeutics Related Hype Analysis
Having access to credible news sources related to Stoke Therapeutics' direct competition is more important than ever and may enhance your ability to predict Stoke Therapeutics' future price movements. Getting to know how Stoke Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Stoke Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADAP | Adaptimmune Therapeutics Plc | (0.04) | 8 per month | 5.37 | 0.05 | 12.87 | (9.09) | 31.05 | |
| FIXX | Homology Medicines | 0.00 | 0 per month | 23.97 | 0.14 | 11.11 | (94.43) | 1,094 | |
| BDTX | Black Diamond Therapeutics | (0.32) | 8 per month | 4.37 | 0.14 | 15.26 | (7.18) | 26.97 | |
| RLAY | Relay TherapeuticsInc | 0.00 | 0 per month | 0.00 | (0.10) | 7.63 | (6.05) | 20.62 | |
| PLRX | Pliant TherapeuticsInc | 0.00 | 0 per month | 0.00 | (0.07) | 4.66 | (5.21) | 15.73 | |
| ARVN | Arvinas | 0.00 | 0 per month | 0.00 | (0.24) | 3.65 | (4.33) | 10.92 | |
| PASG | Passage Bio | 0.03 | 7 per month | 3.97 | 0.09 | 9.68 | (6.43) | 41.15 | |
| BCEL | Atreca Inc | 0.00 | 0 per month | 0.00 | (0.22) | 16.00 | (19.05) | 67.93 | |
| TCRR | Tcr2 Therapeutics | 0.06 | 8 per month | 3.26 | 0.06 | 5.77 | (6.25) | 43.60 |
Stoke Therapeutics Additional Predictive Modules
Most predictive techniques to examine Stoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Stoke using various technical indicators. When you analyze Stoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Stoke Therapeutics Predictive Indicators
The successful prediction of Stoke Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Stoke Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Stoke Therapeutics based on analysis of Stoke Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Stoke Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Stoke Therapeutics's related companies. Story Coverage note for Stoke Therapeutics
The number of cover stories for Stoke Therapeutics depends on current market conditions and Stoke Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Stoke Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Stoke Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Stoke Therapeutics Short Properties
Stoke Therapeutics' future price predictability will typically decrease when Stoke Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Stoke Therapeutics often depends not only on the future outlook of the potential Stoke Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Stoke Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44 M | |
| Cash And Short Term Investments | 201.4 M |
Check out Stoke Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Stoke Stock analysis
When running Stoke Therapeutics' price analysis, check to measure Stoke Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stoke Therapeutics is operating at the current time. Most of Stoke Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stoke Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stoke Therapeutics' price. Additionally, you may evaluate how the addition of Stoke Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Stoke Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.